Test
potential kidney donors of African ancestry for APOL1 risk variants to determine kidney disease risk status.
Potential kidney donors are...
Not exact matches
To test the
potential benefit and safety of targeted hypothermia in
donors on delayed organ function rates in the recipients of their
kidneys, Niemann and his research team conducted a randomized controlled trial in two large organ donation service areas from March 2012 to October 2013.
And in another Penn project, researchers are studying the
potential benefits for some patients to accept
kidney transplants from deceased diabetic
donors, rather than remaining on the organ transplant list for a «lower risk» transplant.
Kenar D. Jhaveri, MD, and Richard Barnett, MD, Feinstein Institute for Medical Research scientists and Northwell Health Department of Internal Medicine nephrologists, published a Letter to the Editor in the New England Journal of Medicine, which profiles a novel drug combination with the
potential to help prevent rejection of a
donor kidney in transplant patients undergoing cancer treatment.
«Cost of
kidney donation may be too much for
potential donors with low income.»
Analysis of the sample can determine if a
kidney donor (
potential live
kidney donor or deceased
kidney donor) or a patient inherited two APOL1 gene renal - risk variants that contribute to poorer renal allograft survival after transplantation.
While the project is in its infancy, the idea represents a
potential solution to the extreme shortage of
donor kidneys.